These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Accelerated coronary atherosclerosis in the allograft heart. Gravanis MB Postgrad Med J; 1994; 70 Suppl 1():S93-8. PubMed ID: 7971656 [No Abstract] [Full Text] [Related]
4. [Allograft vasculopathy in the early phase of orthotopic heart transplantation: angiography, intravascular ultrasound and functional in vivo findings]. Kerber S; Rahmel A; Karbenn U; Heinemann-Vechtel O; Fechtrup C; Lamp B; Block M; Budde T; Hoffmeier A; Weyand M Z Kardiol; 1994 Mar; 83(3):215-24. PubMed ID: 8178545 [TBL] [Abstract][Full Text] [Related]
5. Coronary atherosclerosis of the donor heart--impact on early graft failure. Grauhan O; Siniawski H; Dandel M; Lehmkuhl H; Knosalla C; Pasic M; Weng YG; Hetzer R Eur J Cardiothorac Surg; 2007 Oct; 32(4):634-8. PubMed ID: 17702594 [TBL] [Abstract][Full Text] [Related]
6. [Accelerated coronary atherosclerosis of the transplanted heart]. Cuny C; Eicher JC; Morvan Y; Wolf JE; Louis P Ann Med Interne (Paris); 1993; 144(6):419-24. PubMed ID: 8122825 [No Abstract] [Full Text] [Related]
10. [Metabolic risk factors in heart surgery]. Schwandt P Z Kardiol; 1990; 79 Suppl 4():59-62. PubMed ID: 2082611 [TBL] [Abstract][Full Text] [Related]
11. Transplant vascular disease: role of lipids and proteoglycans. Rahmani M; McDonald PC; Wong BW; McManus BM Can J Cardiol; 2004 Aug; 20 Suppl B():58B-65B. PubMed ID: 15309207 [TBL] [Abstract][Full Text] [Related]
12. CMV and transplant-related coronary atherosclerosis: an immunohistochemical, in situ hybridization, and polymerase chain reaction in situ study. Sambiase NV; Higuchi ML; Nuovo G; Gutierrez PS; Fiorelli AI; Uip DE; Ramires JA Mod Pathol; 2000 Feb; 13(2):173-9. PubMed ID: 10697275 [TBL] [Abstract][Full Text] [Related]
13. The relationship of nodular endocardial infiltrates (Quilty lesions) to survival, patient age, anti-HLA antibodies, and coronary artery disease following heart transplantation. Chu KE; Ho EK; de la Torre L; Vasilescu ER; Marboe CC Cardiovasc Pathol; 2005; 14(4):219-24. PubMed ID: 16009321 [TBL] [Abstract][Full Text] [Related]
14. Adverse outcomes from the use of older donor hearts in cardiac transplant recipients: the pros and cons of expanded donor criteria. Eisen HJ J Am Coll Cardiol; 2004 May; 43(9):1562-4. PubMed ID: 15120812 [No Abstract] [Full Text] [Related]
15. Cardiac allograft vasculopathy: current concepts. Ventura HO; Smart FW; Stapleton DD; Toups T; Price HL J La State Med Soc; 1993 May; 145(5):195-8, 200-2. PubMed ID: 8393471 [TBL] [Abstract][Full Text] [Related]
16. Is the use of artificial hearts the future solution for interim treatment of patients awaiting retransplantation? Cabrol C; Gandjbakhch I; Pavie A; Bors V; Cabrol A; Leger P; Vaissier E; Levasseur JP; Petrie J; Simoneau JC Transplant Proc; 1989 Aug; 21(4):3658-9. PubMed ID: 2669275 [No Abstract] [Full Text] [Related]
17. Are neointimal smooth muscle cells in human cardiac allograft vasculopathy of donor origin? Beranek JT J Heart Lung Transplant; 2005 Aug; 24(8):1121-2. PubMed ID: 16102451 [No Abstract] [Full Text] [Related]